Gene therapy studies are occurring more and more, and the race to develop the first safe and effective treatment for bleeding disorders is growing in competition. Companies like Pfizer, Sangamo Therapeutics, and Uniqure hold many studies and experiments all in the pursuit of a possible treatment.
Also Read - Could This Be the Gene Therapy Champion?
But is the gene therapy market even worth it for these businesses? Well, a recent report by Kuick Research said that the global gene therapy market may witness exponential growth that is driven by the growing number of approvals and a solid clinical pipeline. Neeraj Chawla, Research Head of Kuick Research stated, "As per our report findings, the global gene therapy market is expected to surpass US$ 24 Billion by 2028." This means that by the year 2028, the global market for gene therapy research is predicted to be more worth more than 24 billion U.S. dollars. A detailed summary of the report highlights can be seen here:
"
Global Market Gene Therapy Landscape USD 24 Billion Opportunity
Comprehensive Commercial & Clinical insight on 16 Approved Gene Therapies
Gene Therapy Products Dosage & Price Analysis
Comprehensive Clinical Insight On 1700 Gene Therapies In Clinical Trials
Information On 45 Orphan Designated Gene Therapies By Indication, Country, Company
Global Gene Therapy Clinical Trials Insight By Phase, Country, Formulations, Company, Indication, Target
Global & Regional Market Insight
"
You can read the full statement here: Read More
Want to learn more about bleeding disorders? Sign up for our newsletter here! SIGN UP
Comentarios